Clinical-stage biotechnology developer of gene therapies to save and restore sight for people with rare and prevalent ocular diseases. Pipeline focuses on blinding retinal disorders including X-linked retinitis pigmentosa and geographic atrophy secondary to dry age-related macular degeneration.